Process evaluation findings contradict <scp>RCT</scp> results of the <scp>IBD</scp> ‐ <scp>BOOST</scp> digital self‐management intervention for fatigue, pain and faecal urgency in inflammatory bowel disease: A mixed methods study of patient perspecti
Although the RCT found no statistically significant effect of IBD-BOOST on primary outcomes, the process evaluation results revealed perceived benefits in symptom understanding and developing new management strategies. The intervention was well-received, and patients reported improvements in QoL. There was strong patient support for the IBD-BOOST intervention to be freely available to all individuals with IBD.
Authors
- Wladyslawa Czuber‐Dochan (ORCID: https://orcid.org/0000-0002-9889-1248)
- Rona Moss‐Morris (ORCID: https://orcid.org/0000-0002-2927-3446)
- Stephanie Taylor (ORCID: https://orcid.org/0000-0001-7454-6354)
- Christine Norton (ORCID: https://orcid.org/0000-0003-2259-0948)
- Vari Wileman (ORCID: https://orcid.org/0000-0002-9673-8047)
- Lesley Dibley (ORCID: https://orcid.org/0000-0001-7964-7672)
- Arooj Fatima (ORCID: https://orcid.org/0000-0002-2180-6789)
- Paramasivan Shankavi
Institutions
- Queen Mary University of London (GB)
- King's College London (GB)
- University of Greenwich (GB)
Publication Details
- Journal
- British Journal of Health Psychology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1111/bjhp.70035
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Department of Health and Social Care
- Tillotts Pharma